Related Experiment Video
Updated: Jul 7, 2025
14:56
An Experimental Paradigm for the Prediction of Post-Operative Pain PPOP
Published on: January 27, 2010
21.4K
Intranasal Oxytocin and Pain Reduction: Testing a Social Cognitive Mediation Model.
Preston Long1, Jamie L Scholl2, Xiaotian Wang3
1Institute for Outcomes Research, Center for Medical Data Science, Medical University of Vienna, 1090 Vienna, Austria.
Brain Sciences
|December 23, 2023
Summary
Intranasal oxytocin enhanced prosocial behaviors and decision-making. This suggests oxytocin may reduce pain perception by increasing trust and cooperation, offering a potential alternative to traditional pain medications.
Area of Science:
- Neuroscience
- Psychology
- Pharmacology
Background:
- Oxytocin is recognized for its roles in social behavior and cognition.
- Emerging research suggests oxytocin influences pain perception and relief.
- The impact of exogenous oxytocin on social cognition and pain remains underexplored.
Purpose of the Study:
- To investigate if intranasal oxytocin modulates pain perception via prosocial behaviors.
- To examine potential moderating effects of life history and genetic polymorphisms on oxytocin's influence.
- To explore oxytocin's effects on social cognition, decision-making, and pain sensitivity.
Main Methods:
- A double-blind, placebo-controlled crossover study involving 43 young adults.
- Intranasal administration of oxytocin (24 IU) or placebo.
- Pain assessment using the cold pressor test, alongside measures of social cognition, decision-making, and genetic markers.
Main Results:
- Oxytocin administration led to increased prosocial cognition and improved decision-making.
- Pain perception was influenced by procedural factors and participant expectations.
- Genetic markers were significant predictors of behavioral trust and cooperation.
Conclusions:
- Intranasal oxytocin may enhance trust and cooperation, potentially reducing pain sensitivity.
- Oxytocin presents a promising avenue for pain management with potentially fewer side effects than current pharmaceuticals.
- Further research into genetic and life history factors could refine oxytocin-based therapeutic strategies.
